| Year |
Citation |
Score |
| 2024 |
Sinha P, Dauphinais M, Carwile ME, Horsburgh CR, Menzies NA. In-kind nutritional supplementation for household contacts of persons with tuberculosis would be cost-effective for reducing tuberculosis incidence and mortality in India: a modeling study. Medrxiv : the Preprint Server For Health Sciences. PMID 38260435 DOI: 10.1101/2023.12.30.23300673 |
0.337 |
|
| 2024 |
Regan M, Li Y, Swartwood NA, Barham T, Asay GRB, Cohen T, Hill AN, Horsburgh CR, Khan A, Marks SM, Myles RL, Salomon JA, Self JL, Menzies NA. Racial and ethnic disparities in diagnosis and treatment outcomes among US-born people diagnosed with tuberculosis, 2003-19: an analysis of national surveillance data. The Lancet. Public Health. 9: e47-e56. PMID 38176842 DOI: 10.1016/S2468-2667(23)00276-1 |
0.522 |
|
| 2023 |
Ekramnia M, Li Y, Haddad MB, Marks SM, Kammerer JS, Swartwood NA, Cohen T, Miller JW, Horsburgh CR, Salomon JA, Menzies NA. Estimated rates of progression to tuberculosis disease for persons infected with Mycobacterium tuberculosis in the United States. Epidemiology (Cambridge, Mass.). 35: 164-173. PMID 38290139 DOI: 10.1097/EDE.0000000000001707 |
0.565 |
|
| 2023 |
Havumaki J, Warren JL, Zelner J, Menzies NA, Calderon R, Contreras C, Lecca L, Becerra MC, Murray M, Cohen T. Spatially-targeted tuberculosis screening has limited impact beyond household contact tracing in Lima, Peru: A model-based analysis. Plos One. 18: e0293519. PMID 37903091 DOI: 10.1371/journal.pone.0293519 |
0.341 |
|
| 2023 |
Clark RA, Portnoy A, Weerasuriya CK, Sumner T, Bakker R, Harris RC, Rade K, Mattoo SK, Tumu D, Menzies NA, White RG. The potential health and economic impacts of new tuberculosis vaccines under varying delivery strategies in Delhi and Gujarat, India: a modelling study. Medrxiv : the Preprint Server For Health Sciences. PMID 37808744 DOI: 10.1101/2023.09.27.23296211 |
0.336 |
|
| 2023 |
Menzies NA, Allwood BW, Dean AS, Dodd PJ, Houben RMGJ, James LP, Knight GM, Meghji J, Nguyen LN, Rachow A, Schumacher SG, Mirzayev F, Cohen T. Global burden of disease due to rifampicin-resistant tuberculosis: a mathematical modeling analysis. Nature Communications. 14: 6182. PMID 37794037 DOI: 10.1038/s41467-023-41937-9 |
0.365 |
|
| 2023 |
Portnoy A, Yamanaka T, Nguhiu P, Nishikiori N, Garcia Baena I, Floyd K, Menzies NA. Costs incurred by people receiving tuberculosis treatment in low-income and middle-income countries: a meta-regression analysis. The Lancet. Global Health. 11: e1640-e1647. PMID 37734806 DOI: 10.1016/S2214-109X(23)00369-8 |
0.355 |
|
| 2023 |
Swartwood NA, Testa C, Cohen T, Marks SM, Hill AN, Beeler Asay G, Cochran J, Cranston K, Randall LM, Tibbs A, Horsburgh CR, Salomon JA, Menzies NA. Tabby2: a user-friendly web tool for forecasting state-level TB outcomes in the United States. Bmc Medicine. 21: 331. PMID 37649031 DOI: 10.1186/s12916-023-02785-y |
0.548 |
|
| 2023 |
Klaassen F, Chitwood MH, Cohen T, Pitzer VE, Russi M, Swartwood NA, Salomon JA, Menzies NA. Changes in population immunity against infection and severe disease from SARS-CoV-2 Omicron variants in the United States between December 2021 and November 2022. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 37074868 DOI: 10.1093/cid/ciad210 |
0.457 |
|
| 2023 |
Rönn MM, Menzies NA, Salomon JA. Vaccination and voting patterns in the United States: analysis of COVID-19 and flu surveys from 2010 to 2022. American Journal of Preventive Medicine. PMID 36893952 DOI: 10.1016/j.amepre.2023.03.001 |
0.375 |
|
| 2023 |
Rönn MM, Li Y, Gift TL, Chesson HW, Menzies NA, Hsu K, Salomon JA. Costs, health benefits, and cost-effectiveness of chlamydia screening and partner notification in the United States, 2000-2019: a mathematical modeling analysis. Sexually Transmitted Diseases. PMID 36804917 DOI: 10.1097/OLQ.0000000000001786 |
0.49 |
|
| 2023 |
Portnoy A, Clark RA, Quaife M, Weerasuriya CK, Mukandavire C, Bakker R, Deol AK, Malhotra S, Gebreselassie N, Zignol M, Sim SY, Hutubessy RCW, Baena IG, Nishikiori N, Jit M, ... ... Menzies NA, et al. The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study. Plos Medicine. 20: e1004155. PMID 36693081 DOI: 10.1371/journal.pmed.1004155 |
0.318 |
|
| 2023 |
Yaesoubi R, You S, Xi Q, Menzies NA, Tuite A, Grad YH, Salomon JA. Generating simple classification rules to predict local surges in COVID-19 hospitalizations. Health Care Management Science. 1-12. PMID 36692583 DOI: 10.1007/s10729-023-09629-4 |
0.414 |
|
| 2022 |
Chitwood MH, Alves LC, Bartholomay P, Couto RM, Sanchez M, Castro MC, Cohen T, Menzies NA. A spatial-mechanistic model to estimate subnational tuberculosis burden with routinely collected data: An application in Brazilian municipalities. Plos Global Public Health. 2: e0000725. PMID 36962578 DOI: 10.1371/journal.pgph.0000725 |
0.35 |
|
| 2022 |
Li Y, Rönn MM, Tuite AR, Chesson HW, Gift TL, Trikalinos TA, Testa C, Bellerose M, Hsu K, Berruti AA, Malyuta Y, Menzies NA, Salomon JA. Estimated costs and quality-adjusted life-years lost due to N. gonorrhoeae infections acquired in 2015 in the United States: A modelling study of overall burden and disparities by age, race/ethnicity, and other factors. Lancet Regional Health. Americas. 16: 100364. PMID 36777156 DOI: 10.1016/j.lana.2022.100364 |
0.5 |
|
| 2022 |
Klaassen F, Chitwood MH, Cohen T, Pitzer VE, Russi M, Swartwood NA, Salomon JA, Menzies NA. Changes in population immunity against infection and severe disease from SARS-CoV-2 Omicron variants in the United States between December 2021 and November 2022. Medrxiv : the Preprint Server For Health Sciences. PMID 36451882 DOI: 10.1101/2022.11.19.22282525 |
0.456 |
|
| 2022 |
Zhu J, Lyatuu G, Sudfeld CR, Kiravu A, Sando D, Machumi L, Minde J, Chisonjela F, Cohen T, Menzies NA. Re-evaluating the health impact and cost-effectiveness of tuberculosis preventive treatment for modern HIV cohorts on antiretroviral therapy: a modelling analysis using data from Tanzania. The Lancet. Global Health. 10: e1646-e1654. PMID 36240830 DOI: 10.1016/S2214-109X(22)00372-2 |
0.313 |
|
| 2022 |
Li Y, de Macedo Couto R, Pelissari DM, Costa Alves L, Bartholomay P, Maciel EL, Sanchez M, Castro MC, Cohen T, Menzies NA. Excess tuberculosis cases and deaths following an economic recession in Brazil: an analysis of nationally representative disease registry data. The Lancet. Global Health. PMID 36049488 DOI: 10.1016/S2214-109X(22)00320-5 |
0.319 |
|
| 2022 |
Chitwood MH, Russi M, Gunasekera K, Havumaki J, Klaassen F, Pitzer VE, Salomon JA, Swartwood NA, Warren JL, Weinberger DM, Cohen T, Menzies NA. Reconstructing the course of the COVID-19 epidemic over 2020 for US states and counties: Results of a Bayesian evidence synthesis model. Plos Computational Biology. 18: e1010465. PMID 36040963 DOI: 10.1371/journal.pcbi.1010465 |
0.487 |
|
| 2022 |
Klaassen F, Chitwood MH, Cohen T, Pitzer VE, Russi M, Swartwood NA, Salomon JA, Menzies NA. Population immunity to pre-Omicron and Omicron SARS-CoV-2 variants in US states and counties through December 1, 2021. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 35717642 DOI: 10.1093/cid/ciac438 |
0.465 |
|
| 2021 |
Klaassen F, Chitwood MH, Cohen T, Pitzer VE, Russi M, Swartwood NA, Salomon JA, Menzies NA. Population immunity to SARS-CoV-2 in US states and counties due to infection and vaccination, January 2020-November 2021. Medrxiv : the Preprint Server For Health Sciences. PMID 34981078 DOI: 10.1101/2021.12.23.21268272 |
0.451 |
|
| 2021 |
Yaesoubi R, You S, Xi Q, Menzies NA, Tuite A, Grad YH, Salomon JA. Simple decision rules to predict local surges in COVID-19 hospitalizations during the winter and spring of 2022. Medrxiv : the Preprint Server For Health Sciences. PMID 34931196 DOI: 10.1101/2021.12.13.21267657 |
0.414 |
|
| 2021 |
Yerramsetti S, Cohen T, Atun R, Menzies NA. Global estimates of paediatric tuberculosis incidence in 2013-19: a mathematical modelling analysis. The Lancet. Global Health. 10: e207-e215. PMID 34895517 DOI: 10.1016/S2214-109X(21)00462-9 |
0.329 |
|
| 2021 |
Marx FM, Hauer B, Menzies NA, Haas W, Perumal N. Targeting screening and treatment for latent tuberculosis infection towards asylum seekers from high-incidence countries - a model-based cost-effectiveness analysis. Bmc Public Health. 21: 2172. PMID 34836526 DOI: 10.1186/s12889-021-12142-4 |
0.404 |
|
| 2021 |
Menzies NA, Quaife M, Allwood BW, Byrne AL, Coussens AK, Harries AD, Marx FM, Meghji J, Pedrazzoli D, Salomon JA, Sweeney S, van Kampen SC, Wallis RS, Houben RMGJ, Cohen T. Lifetime burden of disease due to incident tuberculosis: a global reappraisal including post-tuberculosis sequelae. The Lancet. Global Health. 9: e1679-e1687. PMID 34798027 DOI: 10.1016/S2214-109X(21)00367-3 |
0.547 |
|
| 2021 |
Menzies NA, Shrestha S, Parriott A, Marks SM, Hill AN, Dowdy DW, Shete PB, Cohen T, Salomon JA. The health and economic benefits of tests that predict future progression to tuberculosis disease. Epidemiology (Cambridge, Mass.). PMID 34669631 DOI: 10.1097/EDE.0000000000001418 |
0.56 |
|
| 2021 |
Kim S, Cohen T, Horsburgh CR, Miller JW, Hill AN, Marks SM, Li R, Kammerer JS, Salomon JA, Menzies NA. Trends, mechanisms, and racial/ethnic differences of tuberculosis incidence in the US-born population aged 50 years or older in the United States. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 34323959 DOI: 10.1093/cid/ciab668 |
0.518 |
|
| 2021 |
Earnest R, Rönn MM, Bellerose M, Menon-Johansson AS, Berruti AA, Chesson HW, Gift TL, Hsu KK, Testa C, Zhu L, Malyuta Y, Menzies NA, Salomon JA. Modeling the Cost-Effectiveness of Express Multi-Site Gonorrhea Screening among Men Who Have Sex with Men in the United States. Sexually Transmitted Diseases. PMID 33993161 DOI: 10.1097/OLQ.0000000000001467 |
0.454 |
|
| 2021 |
Yang C, Kang J, Lu L, Guo X, Shen X, Cohen T, Menzies NA. The positive externalities of migrant-based TB control strategy in a Chinese urban population with internal migration: a transmission-dynamic modeling study. Bmc Medicine. 19: 95. PMID 33874940 DOI: 10.1186/s12916-021-01968-9 |
0.342 |
|
| 2021 |
Chitwood MH, Russi M, Gunasekera K, Havumaki J, Pitzer VE, Salomon JA, Swartwood N, Warren JL, Weinberger DM, Cohen T, Menzies NA. Reconstructing the course of the COVID-19 epidemic over 2020 for US states and counties: results of a Bayesian evidence synthesis model. Medrxiv : the Preprint Server For Health Sciences. PMID 33851183 DOI: 10.1101/2020.06.17.20133983 |
0.468 |
|
| 2021 |
Chitwood MH, Pelissari DM, Drummond Marques da Silva G, Bartholomay P, Rocha MS, Sanchez M, Arakaki-Sanchez D, Glaziou P, Cohen T, Castro MC, Menzies NA. Bayesian evidence synthesis to estimate subnational TB incidence: An application in Brazil. Epidemics. 35: 100443. PMID 33676092 DOI: 10.1016/j.epidem.2021.100443 |
0.317 |
|
| 2021 |
Chitwood MH, Pelissari DM, Marques da Silva GD, Bartholomay P, Rocha MS, Arakaki-Sanchez D, Sanchez M, Cohen T, Castro MC, Menzies NA. Trends in Untreated Tuberculosis in Large Municipalities, Brazil, 2008-2017. Emerging Infectious Diseases. 27: 957-960. PMID 33622464 DOI: 10.3201/eid2703.204094 |
0.334 |
|
| 2021 |
James LP, Salomon JA, Buckee CO, Menzies NA. The Use and Misuse of Mathematical Modeling for Infectious Disease Policymaking: Lessons for the COVID-19 Pandemic. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 272989X21990391. PMID 33535889 DOI: 10.1177/0272989X21990391 |
0.442 |
|
| 2021 |
Yaesoubi R, Havumaki J, Chitwood MH, Menzies NA, Gonsalves G, Salomon JA, Paltiel AD, Cohen T. Adaptive Policies to Balance Health Benefits and Economic Costs of Physical Distancing Interventions during the COVID-19 Pandemic. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 272989X21990371. PMID 33504258 DOI: 10.1177/0272989X21990371 |
0.437 |
|
| 2020 |
Hill AN, Cohen T, Salomon JA, Menzies NA. High-resolution estimates of tuberculosis incidence among non-U.S.-born persons residing in the United States, 2000-2016. Epidemics. 33: 100419. PMID 33242759 DOI: 10.1016/j.epidem.2020.100419 |
0.553 |
|
| 2020 |
Hsieh YL, Jahn A, Menzies NA, Yaesoubi R, Salomon JA, Girma B, Gunde L, Eaton JW, Auld A, Odo M, Kiyiika CN, Kalua T, Chiwandira B, Mpunga JU, Mbendra K, et al. Evaluation of 6-Month Versus Continuous Isoniazid Preventive Therapy for Mycobacterium tuberculosis in Adults Living With HIV/AIDS in Malawi. Journal of Acquired Immune Deficiency Syndromes (1999). 85: 643-650. PMID 33177475 DOI: 10.1097/QAI.0000000000002497 |
0.457 |
|
| 2020 |
Menzies NA, Swartwood N, Testa C, Malyuta Y, Hill AN, Marks SM, Cohen T, Salomon JA. Time since infection and risks of future disease for individuals with Mycobacterium tuberculosis infection in the United States. Epidemiology (Cambridge, Mass.). PMID 33009253 DOI: 10.1097/EDE.0000000000001271 |
0.549 |
|
| 2020 |
Tuite AR, Testa C, Rönn M, Bellerose M, Gift T, Fridge J, Molotnikov L, Desmarais C, Berruti A, Menzies N, Malyuta Y, Hsu K, Salomon JA. Exploring how epidemic context influences syphilis screening impact: a mathematical modeling study. Sexually Transmitted Diseases. PMID 32976353 DOI: 10.1097/OLQ.0000000000001249 |
0.488 |
|
| 2020 |
Hsieh YL, Jahn A, Menzies NA, Yaesoubi R, Salomon JA, Girma B, Gunde L, Eaton JW, Auld A, Odo M, Kiyiika CN, Kalua T, Chiwandira B, Mpunga JU, Mbendra K, et al. An evaluation of 6-month versus continuous isoniazid preventive therapy for M. tuberculosis in adults living with HIV/AIDS in Malawi. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 32925361 DOI: 10.1097/Qai.0000000000002497 |
0.518 |
|
| 2020 |
Shrestha S, Parriott A, Menzies NA, Shete PB, Hill AN, Marks SM, Dowdy DW. Estimated Population-level Impact of Using a Six-Week Regimen of Daily Rifapentine to Treat Latent Tuberculosis Infection in the United States. Annals of the American Thoracic Society. PMID 32916062 DOI: 10.1513/Annalsats.202005-574Rl |
0.311 |
|
| 2020 |
Rönn MM, Dunville R, Wang LY, Bellerose M, Malyuta Y, Menzies NA, Aslam M, Lewis F, Walker-Baban C, Asbel L, Parchem S, Masinter L, Perez E, Gift TL, Hsu K, et al. Mathematical modeling study of school-based chlamydia screening: potential impact on chlamydia prevalence in intervention schools and surrounding communities. Bmc Public Health. 20: 1363. PMID 32891137 DOI: 10.1186/S12889-020-09466-Y |
0.477 |
|
| 2020 |
Marx FM, Cohen T, Menzies NA, Salomon JA, Theron G, Yaesoubi R. Cost-effectiveness of post-treatment follow-up examinations and secondary prevention of tuberculosis in a high-incidence setting: a model-based analysis. The Lancet. Global Health. 8: e1223-e1233. PMID 32827484 DOI: 10.1016/S2214-109X(20)30227-8 |
0.621 |
|
| 2020 |
Marks SM, Dowdy DW, Menzies NA, Shete PB, Salomon JA, Parriott A, Shrestha S, Flood J, Hill AN. Policy Implications of Mathematical Modeling of Latent Tuberculosis Infection Testing and Treatment Strategies to Accelerate Tuberculosis Elimination. Public Health Reports (Washington, D.C. : 1974). 135: 38S-43S. PMID 32735183 DOI: 10.1177/0033354920912710 |
0.591 |
|
| 2020 |
Menzies NA, Bellerose M, Testa C, Swartwood N, Malyuta Y, Cohen T, Marks SM, Hill AN, Date AA, Maloney SA, Bowden SE, Grills AW, Salomon JA. Impact of Effective Global Tuberculosis Control on Health and Economic Outcomes in the United States. American Journal of Respiratory and Critical Care Medicine. PMID 32645277 DOI: 10.1164/Rccm.202003-0526Oc |
0.602 |
|
| 2020 |
Portnoy A, Vaughan K, Clarke-Deelder E, Suharlim C, Resch SC, Brenzel L, Menzies NA. Producing Standardized Country-Level Immunization Delivery Unit Cost Estimates. Pharmacoeconomics. PMID 32596785 DOI: 10.1007/S40273-020-00930-6 |
0.341 |
|
| 2020 |
Yaesoubi R, Havumaki J, Chitwood M, Menzies NA, Gonsalves G, Salomon JA, Paltiel AD, Cohen T. Adaptive policies for use of physical distancing interventions during the COVID-19 pandemic. Medrxiv : the Preprint Server For Health Sciences. PMID 32577698 DOI: 10.1101/2020.05.29.20065714 |
0.427 |
|
| 2020 |
Kintu A, Sando D, Okello S, Mutungi G, Guwatudde D, Menzies NA, Danaei G, Verguet S. Integrating care for non-communicable diseases into routine HIV services: key considerations for policy design in sub-Saharan Africa. Journal of the International Aids Society. e25508. PMID 32562370 DOI: 10.1002/Jia2.25508 |
0.309 |
|
| 2020 |
Sando D, Kintu A, Okello S, Kawungezi PC, Guwatudde D, Mutungi G, Muyindike W, Menzies NA, Danaei G, Verguet S. Cost-effectiveness analysis of integrating screening and treatment of selected non-communicable diseases into HIV/AIDS treatment in Uganda. Journal of the International Aids Society. e25507. PMID 32562364 DOI: 10.1002/Jia2.25507 |
0.329 |
|
| 2020 |
Earnest R, Rönn MM, Bellerose M, Gift TL, Berruti AA, Hsu KK, Testa C, Zhu L, Malyuta Y, Menzies NA, Salomon JA. Population-Level Benefits of Extragenital Gonorrhea Screening among Men Who Have Sex with Men: An Exploratory Modeling Analysis. Sexually Transmitted Diseases. PMID 32355108 DOI: 10.1097/Olq.0000000000001189 |
0.506 |
|
| 2020 |
Zhu L, Menzies NA, Wang J, Linas BP, Goodreau SM, Salomon JA. Estimation and correction of bias in network simulations based on respondent-driven sampling data. Scientific Reports. 10: 6348. PMID 32286412 DOI: 10.1038/S41598-020-63269-0 |
0.455 |
|
| 2020 |
Quaife M, Houben RMGJ, Allwood B, Cohen T, Coussens AK, Harries AD, van Kampen S, Marx FM, Sweeney S, Wallis RS, Menzies NA. Post-tuberculosis mortality and morbidity: valuing the hidden epidemic. The Lancet. Respiratory Medicine. PMID 32057300 DOI: 10.1016/S2213-2600(20)30039-4 |
0.324 |
|
| 2019 |
Rönn MM, Testa C, Tuite AR, Chesson HW, Gift TL, Schumacher C, Williford SL, Zhu L, Bellerose M, Earnest R, Malyuta Y, Hsu KK, Salomon JA, Menzies NA. The potential population-level impact of different gonorrhea screening strategies in Baltimore and San Francisco: an exploratory mathematical modeling analysis. Sexually Transmitted Diseases. PMID 31842089 DOI: 10.1097/Olq.0000000000001108 |
0.535 |
|
| 2019 |
Munk C, Portnoy A, Suharlim C, Clarke-Deelder E, Brenzel L, Resch SC, Menzies NA. Systematic review of the costs and effectiveness of interventions to increase infant vaccination coverage in low- and middle-income countries. Bmc Health Services Research. 19: 741. PMID 31640687 DOI: 10.1186/S12913-019-4468-4 |
0.331 |
|
| 2019 |
Menzies NA, Parriott A, Shrestha S, Dowdy DW, Cohen T, Salomon JA, Marks SM, Hill AN, Winston CA, Asay G, Barry P, Readhead A, Flood J, Kahn JG, Shete PB. Comparative Modelling of Tuberculosis Epidemiology and Policy Outcomes in California. American Journal of Respiratory and Critical Care Medicine. PMID 31626560 DOI: 10.1164/Rccm.201907-1289Oc |
0.626 |
|
| 2019 |
Clarke-Deelder E, Vassall A, Menzies NA. Estimators Used in Multisite Healthcare Costing Studies in Low- and Middle-Income Countries: A Systematic Review and Simulation Study. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 22: 1146-1153. PMID 31563257 DOI: 10.1016/J.Jval.2019.05.007 |
0.316 |
|
| 2019 |
Rönn MM, Menzies NA, Gift TL, Chesson HW, Trikalinos TA, Bellerose M, Malyuta Y, Berruti A, Gaydos CA, Hsu KK, Salomon JA. Potential for Point-of-Care Tests to Reduce Chlamydia-associated Burden in the United States: A Mathematical Modeling Analysis. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 31504314 DOI: 10.1093/Cid/Ciz519 |
0.515 |
|
| 2019 |
Isanaka S, Barnhart DA, McDonald CM, Ackatia-Armah RS, Kupka R, Doumbia S, Brown KH, Menzies NA. Cost-effectiveness of community-based screening and treatment of moderate acute malnutrition in Mali. Bmj Global Health. 4: e001227. PMID 31139441 DOI: 10.1136/Bmjgh-2018-001227 |
0.305 |
|
| 2019 |
Menzies NA, McQuaid CF, Gomez GB, Siroka A, Glaziou P, Floyd K, White RG, Houben RMGJ. Improving the quality of modelling evidence used for tuberculosis policy evaluation. The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease. 23: 387-395. PMID 31053179 DOI: 10.5588/Ijtld.18.0660 |
0.416 |
|
| 2019 |
Houben RMGJ, Esmail H, Emery JC, Joslyn LR, McQuaid CF, Menzies NA, Sanz J, Shrestha S, White RG, Yang C, Cobelens F. Spotting the old foe-revisiting the case definition for TB. The Lancet. Respiratory Medicine. 7: 199-201. PMID 30823971 DOI: 10.1016/S2213-2600(19)30038-4 |
0.405 |
|
| 2019 |
Rönn MM, Tuite AR, Menzies NA, Wolf EE, Gift TL, Chesson HW, Torrone E, Berruti A, Mazzola E, Galer K, Hsu K, Salomon JA. The Impact of Screening and Partner Notification on Chlamydia in the United States, 2000-2015: Evaluation of Epidemiologic Trends Using a Pair-Formation Transmission Model. American Journal of Epidemiology. PMID 30608525 DOI: 10.1093/Aje/Kwy272 |
0.565 |
|
| 2018 |
Menzies NA, Hill AN, Cohen T, Salomon JA. The impact of migration on tuberculosis in the United States. The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease. 22: 1392-1403. PMID 30606311 DOI: 10.5588/Ijtld.17.0185 |
0.609 |
|
| 2018 |
Cudahy PGT, Andrews JR, Bilinski A, Dowdy DW, Mathema B, Menzies NA, Salomon JA, Shrestha S, Cohen T. Spatially targeted screening to reduce tuberculosis transmission in high-incidence settings. The Lancet. Infectious Diseases. PMID 30554997 DOI: 10.1016/S1473-3099(18)30443-2 |
0.608 |
|
| 2018 |
Trauer JM, Dodd PJ, Gomes MGM, Gomez GB, Houben RM, McBryde ES, Melsew YA, Menzies NA, Arinaminpathy N, Shrestha S, Dowdy DW. The Importance of Heterogeneity to the Epidemiology of Tuberculosis. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 30383204 DOI: 10.1093/Cid/Ciy938 |
0.405 |
|
| 2018 |
Menzies NA, Cohen T, Salomon JA. Evidence sources on the natural history of latent tuberculosis infection. The Lancet. Infectious Diseases. 18: 834-835. PMID 30064672 DOI: 10.1016/S1473-3099(18)30406-7 |
0.547 |
|
| 2018 |
Tuite AR, Rönn MM, Wolf EE, Gift TL, Chesson HW, Berruti A, Galer K, Menzies NA, Hsu K, Salomon JA. Estimated impact of screening on gonorrhea epidemiology in the United States: insights from a mathematical model. Sexually Transmitted Diseases. PMID 29894368 DOI: 10.1097/Olq.0000000000000876 |
0.557 |
|
| 2018 |
Chatterjee S, Ghosh A, Das P, Menzies NA, Laxminarayan R. Determinants of cost of routine immunization programme in India. Vaccine. PMID 29776749 DOI: 10.1016/J.Vaccine.2018.05.006 |
0.328 |
|
| 2018 |
Menzies NA, Cohen T, Hill AN, Yaesoubi R, Galer K, Wolf E, Marks SM, Salomon JA. Prospects for Tuberculosis Elimination in the United States: Results of a Transmission Dynamic Model. American Journal of Epidemiology. PMID 29762657 DOI: 10.1093/Aje/Kwy094 |
0.616 |
|
| 2018 |
Menzies NA, Wolf E, Connors D, Bellerose M, Sbarra AN, Cohen T, Hill AN, Yaesoubi R, Galer K, White PJ, Abubakar I, Salomon JA. Progression from latent infection to active disease in dynamic tuberculosis transmission models: a systematic review of the validity of modelling assumptions. The Lancet. Infectious Diseases. PMID 29653698 DOI: 10.1016/S1473-3099(18)30134-8 |
0.591 |
|
| 2018 |
Wallis RS, Cohen T, Menzies NA, Churchyard G. Pan-tuberculosis regimens: an argument for. The Lancet. Respiratory Medicine. 6: 239-240. PMID 29595501 DOI: 10.1016/S2213-2600(18)30096-1 |
0.415 |
|
| 2018 |
Marx FM, Yaesoubi R, Menzies NA, Salomon JA, Bilinski A, Beyers N, Cohen T. Tuberculosis control interventions targeted to previously treated people in a high-incidence setting: a modelling study. The Lancet. Global Health. PMID 29472018 DOI: 10.1016/S2214-109X(18)30022-6 |
0.57 |
|
| 2017 |
Verguet S, Riumallo-Herl C, Gomez GB, Menzies NA, Houben RMGJ, Sumner T, Lalli M, White RG, Salomon JA, Cohen T, Foster N, Chatterjee S, Sweeney S, Baena IG, Lönnroth K, et al. Catastrophic costs potentially averted by tuberculosis control in India and South Africa: a modelling study. The Lancet. Global Health. 5: e1123-e1132. PMID 29025634 DOI: 10.1016/S2214-109X(17)30341-8 |
0.592 |
|
| 2017 |
Geng F, Suharlim C, Brenzel L, Resch SC, Menzies NA. The cost structure of routine infant immunization services: a systematic analysis of six countries. Health Policy and Planning. PMID 28575193 DOI: 10.1093/Heapol/Czx067 |
0.305 |
|
| 2017 |
Rönn MM, Wolf EE, Chesson H, Menzies NA, Galer K, Gorwitz R, Gift T, Hsu K, Salomon JA. The Use of Mathematical Models of Chlamydia Transmission to Address Public Health Policy Questions: A Systematic Review. Sexually Transmitted Diseases. 44: 278-283. PMID 28407643 DOI: 10.1097/Olq.0000000000000598 |
0.507 |
|
| 2017 |
Menzies NA, Soeteman DI, Pandya A, Kim JJ. Bayesian Methods for Calibrating Health Policy Models: A Tutorial. Pharmacoeconomics. PMID 28247184 DOI: 10.1007/S40273-017-0494-4 |
0.321 |
|
| 2017 |
Menzies NA, Gomez GB, Vassall A. Modelling approaches for tuberculosis: are they realistic? - Authors' reply. The Lancet. Global Health. 5: e269. PMID 28193392 DOI: 10.1016/S2214-109X(17)30051-7 |
0.385 |
|
| 2017 |
Rönn MM, Tuite A, Menzies NA, Gift T, Chesson H, Torrone E, Wolf EE, Galer K, Hsu K, Salomon JA. O01.6 Evaluating chlamydia trends in the united states 2000–2015 using a pair formation transmission model Sexually Transmitted Infections. 93. DOI: 10.1136/Sextrans-2017-053264.5 |
0.545 |
|
| 2016 |
Isanaka S, Menzies NA, Sayyad J, Ayoola M, Grais RF, Doyon S. Cost analysis of the treatment of severe acute malnutrition in West Africa. Maternal & Child Nutrition. PMID 27921381 DOI: 10.1111/Mcn.12398 |
0.3 |
|
| 2016 |
Menzies NA, Gomez GB, Bozzani F, Chatterjee S, Foster N, Baena IG, Laurence YV, Qiang S, Siroka A, Sweeney S, Verguet S, Arinaminpathy N, Azman AS, Bendavid E, Chang ST, et al. Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models. The Lancet. Global Health. PMID 27720689 DOI: 10.1016/S2214-109X(16)30265-0 |
0.592 |
|
| 2016 |
Houben RM, Menzies NA, Sumner T, Huynh GH, Arinaminpathy N, Goldhaber-Fiebert JD, Lin HH, Wu CY, Mandal S, Pandey S, Suen SC, Bendavid E, Azman AS, Dowdy DW, Bacaër N, et al. Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models. The Lancet. Global Health. PMID 27720688 DOI: 10.1016/S2214-109X(16)30199-1 |
0.587 |
|
| 2015 |
Chindelevitch L, Menzies NA, Pretorius C, Stover J, Salomon JA, Cohen T. Evaluating the potential impact of enhancing HIV treatment and tuberculosis control programmes on the burden of tuberculosis. Journal of the Royal Society, Interface / the Royal Society. 12. PMID 25878131 DOI: 10.1098/Rsif.2015.0146 |
0.598 |
|
| 2015 |
Menzies NA, Cohen T, Murray M, Salomon JA. Effect of empirical treatment on outcomes of clinical trials of diagnostic assays for tuberculosis. The Lancet. Infectious Diseases. 15: 16-7. PMID 25541164 DOI: 10.1016/S1473-3099(14)71026-6 |
0.515 |
|
| 2014 |
Dowdy DW, Houben R, Cohen T, Pai M, Cobelens F, Vassall A, Menzies NA, Gomez GB, Langley I, Squire SB, White R. Impact and cost-effectiveness of current and future tuberculosis diagnostics: the contribution of modelling. The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease. 18: 1012-8. PMID 25189546 DOI: 10.5588/Ijtld.13.0851 |
0.444 |
|
| 2014 |
Keebler D, Revill P, Braithwaite S, Phillips A, Blaser N, Borquez A, Cambiano V, Ciaranello A, Estill J, Gray R, Hill A, Keiser O, Kessler J, Menzies NA, Nucifora KA, et al. Cost-effectiveness of different strategies to monitor adults on antiretroviral treatment: a combined analysis of three mathematical models. The Lancet. Global Health. 2: e35-43. PMID 25104633 DOI: 10.1016/S2214-109X(13)70048-2 |
0.334 |
|
| 2014 |
Eaton JW, Menzies NA, Stover J, Cambiano V, Chindelevitch L, Cori A, Hontelez JA, Humair S, Kerr CC, Klein DJ, Mishra S, Mitchell KM, Nichols BE, Vickerman P, Bakker R, et al. Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models. The Lancet. Global Health. 2: e23-34. PMID 25104632 DOI: 10.1016/S2214-109X(13)70172-4 |
0.521 |
|
| 2014 |
Hallett TB, Eaton JW, Menzies N. Beware of using invalid transmission models to guide HIV health policy - authors' reply. The Lancet. Global Health. 2: e261. PMID 25103163 DOI: 10.1016/S2214-109X(14)70206-2 |
0.319 |
|
| 2014 |
Pretorius C, Menzies NA, Chindelevitch L, Cohen T, Cori A, Eaton JW, Fraser C, Gopalappa C, Hallett TB, Salomon JA, Stover J, White RG, Dodd PJ. The potential effects of changing HIV treatment policy on tuberculosis outcomes in South Africa: results from three tuberculosis-HIV transmission models. Aids (London, England). 28: S25-34. PMID 24468944 DOI: 10.1097/Qad.0000000000000085 |
0.578 |
|
| 2013 |
Eaton JW, Menzies NA, Stover J, Cambiano V, Chindelevitch L, Cori A, Hontelez JA, Humair S, Kerr CC, Klein DJ, Mishra S, Mitchell KM, Nichols BE, Vickerman P, Bakker R, et al. Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models. The Lancet. Global Health. 2: 23-34. PMID 25083415 DOI: 10.1016/S2214-109X(13)70172-4 |
0.479 |
|
| 2012 |
Menzies NA, Cohen T, Lin HH, Murray M, Salomon JA. Population health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluation. Plos Medicine. 9: e1001347. PMID 23185139 DOI: 10.1371/Journal.Pmed.1001347 |
0.605 |
|
| 2012 |
Menzies NA, Berruti AA, Blandford JM. The determinants of HIV treatment costs in resource limited settings. Plos One. 7: e48726. PMID 23144946 DOI: 10.1371/Journal.Pone.0048726 |
0.314 |
|
| 2011 |
Menzies NA, Salomon JA. Non-monotonicity in the episodic random utility model. Health Economics. 20: 1523-31. PMID 22025393 DOI: 10.1002/Hec.1683 |
0.515 |
|
| 2011 |
Menzies NA, Berruti AA, Berzon R, Filler S, Ferris R, Ellerbrock TV, Blandford JM. The cost of providing comprehensive HIV treatment in PEPFAR-supported programs. Aids (London, England). 25: 1753-60. PMID 21412127 DOI: 10.1097/Qad.0B013E3283463Eec |
0.327 |
|
| Show low-probability matches. |